A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BoNT-A / botulinum toxin type A

[Related PubMed/MEDLINE]
Total Number of Papers: 687
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BoNT-A  (>> Co-occurring Abbreviation)
Long Form:   botulinum toxin type A
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Do randomised controlled trials evaluating functional outcomes following botulinum neurotoxin-A align with focal spasticity guidelines? A systematic review. RCT
2022 Effects of Botulinum Toxin Type A on the Psychosocial Features of Myofascial Pain TMD Subjects: A Randomized Controlled Trial. CPI, MFP, OA, RDC/TMD, SS
2021 A First Clinical Trial on Botulinum Toxin-A for Chronic Muscle-Related Pain in Cerebral Palsy. CP
2021 A Study of Botulinum Toxin A for Ultraviolet-Induced Hyperpigmentation: A Randomized Controlled Trial. UV
2021 Analgesic potential of different available commercial brands of botulinum neurotoxin-A in formalin-induced orofacial pain in mice. ---
2021 Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease. ---
2021 Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice. PS-SMD
2021 Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders. CM, PHs, PRISMA
2021 Blink index as a response predictor of blepharospasm to botulinum neurotoxin-A treatment. BSP, CT, IBT, OS, PBR
10  2021 Botulinum Neurotoxin Type A as an Adjuvant to Reduce Scarring After Dermatological Surgery. ---
11  2021 Botulinum Toxin A Ameliorates Neuroinflammation in the MPTP and 6-OHDA-Induced Parkinson's Disease Models. PD
12  2021 Botulinum Toxin A and Osteosarcopenia in Experimental Animals: A Scoping Review. ---
13  2021 Botulinum Toxin A for Chronic Exertional Compartment Syndrome: A Retrospective Study of 16 Upper- and Lower-Limb Cases. CECS
14  2021 Botulinum toxin injections as salvage therapy is beneficial for management of patellofemoral pain syndrome. PFPS, QoL, VL, VMO
15  2021 Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis. ---
16  2021 Botulinum toxin treatment for difficult-to-treat finger pressure ulcers caused by severe hand flexion: case report. PU
17  2021 Botulinum toxin type A and acupuncture for masticatory myofascial pain: a randomized clinical trial. EMG, PPT, SS, TMD
18  2021 Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes? ---
19  2021 Botulinum Toxin Type A in the Spasticity of Cerebral Palsy Related to Congenital Zika Syndrome: An Observational Study. CP, CZS, GMFCS, PGI-I
20  2021 Botulinum Toxin Type A injections for pediatric spasticity: Keeping our patients informed and practices safe. AE, serious AEs
21  2021 Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience. ---
22  2021 Botulinum toxin type A treatment is associated with improved social and psychological behavior: A retrospective study. ---
23  2021 Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. FDA
24  2021 Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis. CGRP mAbs, SMD
25  2021 Changes in Cortical Excitability and Parkinson Tremor After Botulinum Toxin Therapy. ICF, LICI, PD, ppTMS, SICI
26  2021 Characteristics and treatment effectiveness of the nummular headache: a systematic review and analysis of 110 cases. NH, NSAIDs
27  2021 Chronic Exertional Compartment Syndrome Treated With Botulinum Toxin-A Yielding 36-Month Total Symptom Relief: A Case Report. CECS
28  2021 Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial. ARAT, FMA, MAS, RFE
29  2021 Complications of facial cosmetic botulinum toxin A injection: analysis of the UK Medicines & Healthcare Products Regulatory Agency registry and literature review. FOI, MHRA, UK
30  2021 Complications of Preseptal Versus Pretarsal Botulinum Toxin Injection in Benign Essential Blepharospasm: A Randomized Controlled Trial. BEB, CI, MRD, PST, PTS
31  2021 Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature. NMJ, SFEMG
32  2021 Correction to the article "Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity", published on Acta Med Port 2020 Nov;33(11):761-764. ---
33  2021 Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity. MAS, PSS, SEPs
34  2021 Cost Efficiency Analysis for Spasticity Management Based on Physician Botulinum Toxin Prescribing Habits. ---
35  2021 Cost of peripheral facial palsy treatment with Botulinum Toxin type A. FP
36  2021 COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study. QoL
37  2021 Current Australian clinical practice in use of botulinum toxin-A to manage paediatric hypertonicity. ---
38  2021 Developing a Consistent, Reproducible Botulinum Toxin Type A Dosing Method for Upper Limb Tremor by Kinematic Analysis. ET, PD
39  2021 Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naive subjects. EP, MP
40  2021 Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study. MAS, PSS
41  2021 Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia. CD
42  2021 Effect of muscle selection for botulinum neurotoxin treatment on spasticity in patients with post-stroke elbow flexor muscle over-activity: an observational prospective study. ---
43  2021 Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy. MT
44  2021 Efficacy and Optimal Dose of Botulinum Toxin A in Post-Stroke Lower Extremity Spasticity: A Systematic Review and Meta-Analysis. PLES, RCTs
45  2021 Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art. ---
46  2021 European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. ITB
47  2021 Four-dimensional ultrasound biometry following botulinum toxin type A injection to the pelvic floor. PFTM, VAS
48  2021 Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction. NLUTD, SCI, UTI
49  2021 Goal Attainment: A Clinically Meaningful Measure of Success of Botulinum Toxin-A Treatment for Lower Limb Spasticity in Ambulatory Patients. MAS
50  2021 High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice. ---
51  2021 Influence of botulinum toxin type A esthetic injections on facial expressions. ---
52  2021 Intermittent serial casting for wrist flexion deformity in children with spastic cerebral palsy: a randomized controlled trial. CP, MAS, PROM
53  2021 Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary. CP, ROM
54  2021 Is low dose of botulinum toxin effective in controlling chronic pain in sleep bruxism, awake bruxism, and temporomandibular disorder? AB, SB, TMD, VAS
55  2021 Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study. ULIS-III
56  2021 Management of gummy smile using botulinum toxin: a case series. VAS
57  2021 Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit. BNN
58  2021 Mechanism and Priority of Botulinum Neurotoxin A versus Sacral Neuromodulation for Refractory Overactive Bladder: A Review. OAB, ROAB, SNM
59  2021 Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders. ESW, IC/BPS
60  2021 Novel Botulinum Toxin Injection Protocols for Parkinson Tremor and Essential Tremor - the Yale Technique and Sensor-Based Kinematics Procedure for Safe and Effective Treatment. ET, PD
61  2021 Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders. SMGE, VAS
62  2021 Protocol for The Toxin Study: Understanding clinical and patient reported response of children and young people with cerebral palsy to intramuscular lower limb Botulinum neurotoxin-A injections, exploring all domains of the ICF. A pragmatic longitudinal observational study using a prospective one-group repeated measures design. CYPwCP, GMFCS, HRQoL
63  2021 Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia. ADSD, EMG, LEMG, NSS, VHI-10
64  2021 Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial. ---
65  2021 Repetitive peripheral magnetic stimulation for the assessment of wrist spasticity: reliability, validation and correlation with clinical measures. AS, CS, HS, iMR, rPMS
66  2021 Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients. OAB, SNM
67  2021 Scientific review of the aesthetic uses of botulinum toxin type A. ACh
68  2021 Spasticity in practice (SPACE): an international non-interventional study of botulinum neurotoxin type A in treatment-naive subjects with spasticity. HRQoL, SPACE
69  2021 Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial. ---
70  2021 Synergic use of botulinum toxin injection and radial extracorporeal shockwave therapy in Multiple Sclerosis spasticity. MAS, MS, MTS, rESW
71  2021 Targeted Physical Therapy Combined with Spasticity Management Changes Motor Development Trajectory for a 2-Year-Old with Cerebral Palsy. CP, START-Play
72  2021 The Central Effects of Botulinum Toxin in Dystonia and Spasticity. ---
73  2021 The Effects of Distributed vs. Condensed Schedule for Robot-Assisted Training with Botulinum Toxin A Injection for Spastic Upper Limbs in Chronic Post-Stroke Subjects. RT
74  2021 The patient pathway for overactive bladder management: A quantitative analysis. OAB
75  2021 The Use of Botulinum Toxin A as an Adjunctive Therapy in the Management of Chronic Musculoskeletal Pain: A Systematic Review with Meta-Analysis. RCTs, RoB
76  2021 Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women. DV, VUDS
77  2021 Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors. EUS
78  2021 Topiramate, acupuncture, and BoNT-A for chronic migraine: a network meta-analysis. CENTRAL, RCTs, SMD
79  2021 Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report. MS, tDCS
80  2021 Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation. MG, SOL, US
81  2021 Ultrasonographic Evaluation of Three Approaches for Botulinum Toxin Injection into Tibialis Posterior Muscle in Chronic Stroke Patients with Equinovarus Foot: An Observational Study. SEV, TP
82  2021 Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters. HFS, HFS score, HRQoL, VAS
83  2021 Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury? NDO, SCI
84  2021 [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation]. DAS, GAS, ULIS-III
85  2021 [Sevoflurane sedation protocol in children with cerebral palsy undergoing botulinum toxin-A injections]. AE, CP
86  2021 [Treatment satisfaction in patients with cervical dystonia : Subgroup analysis of INTEREST-IN-CD-2]. CD, TWSTRS
87  2020 A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients. DO, MUS, OABSS, UIOS
88  2020 A Retrospective Cost Analysis of Patients Who Switched from OnabotulinumtoxinA to IncobotulinumtoxinA in a Private Neurology Practice. ---
89  2020 Access to Focal Spasticity Care: A Cross Canada Survey of Physiatrists. ---
90  2020 Altered sensory system activity and connectivity patterns in adductor spasmodic dysphonia. ADSD
91  2020 Bioactivity of abobotulinum toxin is preserved till 2weeks upon storage at room temperature: Half body comparative study on rabbit model. aboBoNT-A
92  2020 Botox rechallenge-An additional tool in the management of an incompletely emptying bladder and inadequate overactive symptom control following sacral neuromodulation. DO-DU, OAB, PVR, SNM
93  2020 Botulinum Neurotoxin-A Injection in Adult Cervical Dystonia and Spastic Paresis: Results From the INPUT (INjection Practice, Usage and Training) Survey. CD, HCPs, PMR, SP
94  2020 Botulinum toxin A injection in the treatment of chronic pelvic pain with hypertonic pelvic floor in women: Treatment techniques and results. CPP
95  2020 Botulinum Toxin and Pain. ---
96  2020 Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction. ---
97  2020 Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo-Controlled Trial. EMG, RM-ANOVA, SB
98  2020 Botulinum toxin type A for hand tremor: a meta-analysis of randomised controlled trials. AEs, CI, ET, MS, SMD, SMD
99  2020 Botulinum Toxin Type A Injection for Mammoplasty and Abdominoplasty Scar Management: A Split-Scar Double-Blinded Randomized Controlled Study. SBSES
100  2020 Botulinum Toxin Type A Injections Impact Hamstring Muscles and Gait Parameters in Children with Flexed Knee Gait. CP, FKG, GMFM, MAS, MTS, SM